Drug reference
Infertility in women with proven hypopituitarism or who have not responded to clomifene | Superovulation treatment for assisted conception (such as in vitro fertilisation) ▶BY SUBCUTANEOUS INJECTION, OR BY DEEP INTRAMUSCULAR INJECTION ▶Adult (female): Adjusted according to response.
PDF page 809
Ovarian cysts (not caused by polycystic ovarian syndrome). tumours of breast. tumours of hypothalamus. tumours of ovaries. tumours of pituitary . tumours of uterus. vaginal bleeding of unknown cause
PDF page 809
Acute porphyrias p. 1120
PDF page 809
Urofollitropin is purified extract of human post- menopausal urine containing follicle-stimulating hormone (FSH).
PDF page 809
▶Common or very common Breast tenderness. constipation. diarrhoea. gastrointestinal discomfort. headache. hot flush. increased risk of infection. muscle spasms. nausea. ovarian hyperstimulation syndrome. pain. pelvic pain. rash. vaginal discharge. vaginal haemorrhage. vomiting
PDF page 809
Avoid.
PDF page 809
Avoid.
PDF page 809
There can be variation in the licensing of different medicines containing the same drug. Powder and solvent for solution for injection ▶Fostimon (Pharmasure Ltd) Follicle stimulating hormone human (as Urofollitropin) Endocrine system 75 unit Fostimon 75unit powder and solvent for solution for injection vials | 10 vial P £279.00 Follicle stimulating hormone human (as Urofollitropin) 150 unit Fostimon 150unit powder and solvent for solution for injection vials | 10 vial P £558.00 7.4 Growth hormone disorders PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES › GROWTH HORMONE RECEPTOR ANTAGONISTS
PDF page 810
Conception and contraception Patients planning to conceive should be warned that there is a risk of multiple pregnancy.
PDF page 810
Adjusted according to response.
First-line fragment. Read the complete Indications and Dose section above.
PDF page 809
